Welcome, Guest. Please login or register.
October 07, 2024, 06:37:47 am

Login with username, password and session length


Members
Stats
  • Total Posts: 55130
  • Total Topics: 4851
  • Online Today: 247
  • Online Ever: 3061
  • (September 25, 2024, 11:40:40 pm)
Users Online
Users: 0
Guests: 170
Total: 170

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Zepatier Beats Almost All Acute Hepatitis C in Just 8 Weeks  (Read 4183 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Zepatier Beats Almost All Acute Hepatitis C in Just 8 Weeks
« on: August 24, 2018, 10:44:21 am »
Eight weeks of Merck’s Zepatier (grazoprevir/elbasvir) boasted a near-perfect hepatitis C virus (HCV) cure rate among a group of European men who have sex with men (MSM) in a recent study, the National AIDS Treatment Advocacy Project (NATAP) reports. These men had a very high reinfection rate, with 5 percent of them testing positive for a new hep C infection within 12 weeks of finishing Zepatier treatment.

Researchers conducted a single-arm open-label trial, known as the Dutch Acute HCV in HIV Study-2 (DAHHS-2), of eight weeks of Zepatier among 86 people from the Netherlands and Belgium who had acute, or recently contracted, hep C. They presented their findings at the International AIDS Conference in Amsterdam (AIDS 2018).

Read more...
https://www.hepmag.com/article/zepatier-beats-almost-acute-hepatitis-c-just-8-weeks

 


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.